Potential of dendritic-cell immunotherapy for relapse after allogeneic hematopoietic stem cell transplantation, shown by WT1 peptide- and keyhole-limpet-hemocyanin-pulsed, donor-derived dendritic-cell vaccine for acute myeloid leukemia.
Apr 2008 - Am. J. Hematol.; 83(4):1096-8652 [PMID:18081032]
[Kitawaki T] [Kadowaki N] [Kondo T] [Ishikawa T] [Ichinohe T] [Teramukai S] [Fukushima M] [Kasai Y] [Maekawa T] [Uchiyama T]